期刊文献+

人载脂蛋白基因apoAⅠ在毕赤氏酵母中的表达 被引量:2

Expression of Human Apolipoprotein AⅠ Gene in Yeast Pichia pastoris
原文传递
导出
摘要 将化学法合成的apoAⅠ基因插入分泌型载体 pPIC9K .将重组的 pPIC9K apoAⅠ用BglⅡ酶切后 ,转化PichiapastorisGS115菌株 ,筛选获得G4 18高抗性转化子 .转化子经摇瓶发酵和甲醇诱导 ,上清液用SDS PAGE检测 ,有明显的rApoAⅠ表达 .经Phenyl sepharose 6 (FastFlow)疏水层析柱和SephadexG 5 0 (coarse)分子筛层析 ,得到rApoAⅠ蛋白纯品 .经Westernblotting ,N末端氨基酸顺序测定证明 ,毕赤氏酵母表达的rApoAⅠ与人血浆提取的ApoAⅠ基本一致 . ap oAⅠgene,which was chemically synthesized,was inserted into secretion vectors pPIC9 and pPIC9K. The recombined pPIC9K- apo AⅠ was digested by Bgl Ⅱ and transformed into Pichia pastoris strain GS115, then the transformants with high G418 resistance were selected. After the transformants grew in the shaking flask and was induced by methynol, the SDS-PAGE analysis of supernatant showed that they expressed rApoAⅠ in a high level. rApoAⅠwas isolated and purified by Phenyl-sepharose 6 (Fast Flow) and Sephadex G-50 (coarse) gel permeation chromatography. The results obtained through Western blotting and N-terminal amino acid sequence determination indicated that purified rApoAⅠprotein expressed by Pichia pastoris had very similar characteristics compared with those of natural ApoAⅠprotein purified from human serum.
出处 《复旦学报(自然科学版)》 CAS CSCD 北大核心 2004年第2期181-184,189,共5页 Journal of Fudan University:Natural Science
基金 复旦大学Med X基金重点资助项目 上海市科学技术委员会资助项目 (0 2 4 3192 0 4 )
关键词 人载脂蛋白ApoAI 分泌型载体 毕赤氏酵母 蛋白质印迹 N末端氨基酸顺序测定 human apolipoprotein AⅠ secretion vector Pichia pastoris Western blotting N-terminal amino acid sequence determination
  • 相关文献

参考文献9

  • 1鄢盛恺,林其燧.血脂、脂蛋白和载脂蛋白的检测与临床应用[J].中华医学检验杂志,1999,22(4):254-256. 被引量:39
  • 2Fielding C,Fielding P.Molecular physiology of reverse cholesterol transport [J].J Lipid Res,1995,36:211-228.
  • 3Plump A S,Scott C J,Breslow J L.Human apolipoprotein A-gene expression increase high-density lipoprotein and suppresses atherosclerosis in the apoprotein E-deficientmouse [J].Proc Natal Acad Sci USA ,1994,91:9607-9612.
  • 4Schultz J R,Rubin E M.The propertiesof HDL in genetically engineered mice [J].Curn Opin Lipidol ,1994,5:126-132.
  • 5Rubin E M,Krauss R M,Spangler E A,et al .Inhibition of early atherogenesis in Transgenic mice by human apolipoprotein Al [J].Nature,1991,353 (19):265-272 .
  • 6李月彬,吴满平.细胞膜上高密度脂蛋白(HDL)结合蛋白的鉴定[J].生物化学与生物物理学报,1992,24(3):233-238. 被引量:6
  • 7程颖,高卜渝,宋大新,袁汉英,陈永青,李育阳,柳湘,田培坤,顾健人.转甲状腺素蛋白基因在酵母中的表达[J].生物工程学报,1999,15(4):428-433. 被引量:7
  • 8Julius D,Brake A,Blair L,et al .Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-factor [J].Cell,1984,37:1075-1089.
  • 9Carol A S,Richard G B,Jeffrey J C,et al.The intracellular production and secetion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris [J].Gene,1993,136:111-119.

二级参考文献16

  • 1北京大学生物系生物化学教研室.生物化学实验指导[M].,1979.22,43,87.
  • 2顾健人 等.-[J].中国科学:B辑,1991,(4):403-407.
  • 3陈人骏.-[J].中国医学检验杂志,1985,83:151-153.
  • 4孟宪镛 等.-[J].中华消化杂志,1984,4(2):101-102.
  • 5李健斋,中华医学检验杂志,1998年,21卷,5页
  • 6鄢盛恺,中华医学检验杂志,1998年,21卷,19页
  • 7鄢盛恺,中华医学检验杂志,1998年,21卷,328页
  • 8李健斋,临床检验杂志,1997年,15卷,310页
  • 9血脂异常防治对策专题组,中华心血管病杂志,1997年,25卷,169页
  • 10叶水清,动脉粥样硬化与生物化学检验,1997年,45页

共引文献46

同被引文献18

  • 1马文峰,丁满生,郭美锦,庄英萍,储炬,张嗣良.重组人载脂蛋白ApoA-I表达条件的优化[J].微生物学通报,2004,31(6):27-32. 被引量:2
  • 2杨婷婷,赵志安,张彦,宋大新.人载脂蛋白基因apoAⅠ在毕赤氏酵母中的胞内表达[J].复旦学报(自然科学版),2004,43(6):1035-1038. 被引量:2
  • 3马百坤,郭利利,方蓉,徐东刚.人载脂蛋白AⅠ基因的克隆表达及功能[J].中国生物化学与分子生物学报,2005,21(2):273-277. 被引量:3
  • 4Weisgraber K H, Bersot T P, Mahley R W, et al, A-Ⅰ milano apoprotein, Isolation and characterization of a cysteine-containing variant of the A-Ⅰ apoprotein from human high density lipoproteins[J]. J Clin Invest, 1980,66(5) :901-907.
  • 5Franceschini G, Vecchio G, Gianfranceschi G, et al, Apolipoprotein AIMilano, Accelerated binding and dissociation from lipids of a human apolipoprotein variant[J], J Biol Chem, 1982,60(30):16321-16325.
  • 6Chiesa G, Monteggia E, Marchesi M, et al, Recombinant apolipoprotein A-Ⅰ (Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks[J], Circ Res, 2002,90(9):974-980.
  • 7Sirtori C R, Calabresi L, Franceschini G, et al. Cardiovascular status of carriers of the apolipoprotein A-Ⅰ (Milano) mutant: the Limone sul Garda study[J]. Circulation,2001,103(15) : 1949-1954.
  • 8Franceschini G, Calabresi L, Chiesa G, et al. Increased cholesterol efflux potential of sera from ApoA-Ⅰ Milano carriers and transgenic mice[J]. Arterioscler Thromb Vasc Biol, 1999,19(5 ) : 1257-1262.
  • 9Bielicki J K, Forte T M, McCall M R, et al. High density lipoprotein particle size restriction in apolipoprotein A-Ⅰ (Milano) transgenic mice[J]. J Lipid Res, 1997,38(11 ) : 2314-2321.
  • 10Roma P, Gregg R E, Meng M S, et al. In vivo metabolism of a mutant form of apolipoprotein A-Ⅰ , apo A-Ⅰ Milano, associated with familial hypoalphalipoproteinemia[J]. J Clin Invest, 1993,91(4) : 1445-1452.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部